BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
Illegal immigrant's violent confrontation with federal agents in Los Angeles highlights escalating tensions in sanctuary cities amid intensified deportation efforts.
BioMarin reports Q3 revenue growth, but posts a net loss due to higher R&D spending and an acquired IPR&D charge.
Illegal immigrant's violent confrontation with federal agents in Los Angeles highlights escalating tensions in sanctuary cities amid intensified deportation efforts.